These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16495535)

  • 21. Molecular mimicry between Trypanosoma cruzi and host nervous tissues.
    Avila JL
    Acta Cient Venez; 1992; 43(6):330-40. PubMed ID: 1343745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity.
    Yoshida N
    Parasitol Int; 2008 Jun; 57(2):105-9. PubMed ID: 18234547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are there epigenetic controls in Trypanosoma cruzi?
    Elias MC; Faria M
    Ann N Y Acad Sci; 2009 Oct; 1178():285-90. PubMed ID: 19845644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypanosoma cruzi-infected individuals demonstrate varied antibody responses to a panel of trans-sialidase proteins encoded by SA85-1 genes.
    Duthie MS; Cetron MS; Van Voorhis WC; Kahn SJ
    Acta Trop; 2005 Mar; 93(3):317-29. PubMed ID: 15725381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silencing cytokeratin 18 gene inhibits intracellular replication of Trypanosoma cruzi in HeLa cells but not binding and invasion of trypanosomes.
    Claser C; Curcio M; de Mello SM; Silveira EV; Monteiro HP; Rodrigues MM
    BMC Cell Biol; 2008 Dec; 9():68. PubMed ID: 19087356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The heat shock proteins of Trypanosoma cruzi.
    Urményi TP; Silva R; Rondinelli E
    Subcell Biochem; 2014; 74():119-35. PubMed ID: 24264243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
    Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses.
    Wizel B; Nunes M; Tarleton RL
    J Immunol; 1997 Dec; 159(12):6120-30. PubMed ID: 9550413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. REGULATION of the EXTRACELLULAR MATRIX INTERACTOME by Trypanosoma cruzi.
    Cardenas TC; Johnson CA; Pratap S; Nde PN; Furtak V; Kleshchenko YY; Lima MF; Villalta F
    Open Parasitol J; 2010; 4():72-76. PubMed ID: 21499436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
    Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual genome-wide RNAi screening to identify human host factors required for Trypanosoma cruzi infection.
    Genovesio A; Giardini MA; Kwon YJ; de Macedo Dossin F; Choi SY; Kim NY; Kim HC; Jung SY; Schenkman S; Almeida IC; Emans N; Freitas-Junior LH
    PLoS One; 2011; 6(5):e19733. PubMed ID: 21625474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular cloning of a Trypanosoma cruzi cell surface casein kinase II substrate, Tc-1, involved in cellular infection.
    Augustine SA; Kleshchenko YY; Nde PN; Pratap S; Ager EA; Burns JM; Lima MF; Villalta F
    Infect Immun; 2006 Jul; 74(7):3922-9. PubMed ID: 16790765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Gp85 surface glycoproteins from Trypanosoma cruzi.
    Mattos EC; Tonelli RR; Colli W; Alves MJ
    Subcell Biochem; 2014; 74():151-80. PubMed ID: 24264245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infection by Trypanosoma cruzi. Identification of a parasite ligand and its host cell receptor.
    Magdesian MH; Giordano R; Ulrich H; Juliano MA; Juliano L; Schumacher RI; Colli W; Alves MJ
    J Biol Chem; 2001 Jun; 276(22):19382-9. PubMed ID: 11278913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trypanosoma cruzi: the effect of nitric oxide synthesis inhibition on the CD4 T cell response to the trans-sialidase superfamily.
    Millar AE; Kahn SJ
    Exp Parasitol; 2000 Feb; 94(2):84-91. PubMed ID: 10673344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trypanosoma cruzi surface mucins: host-dependent coat diversity.
    Buscaglia CA; Campo VA; Frasch AC; Di Noia JM
    Nat Rev Microbiol; 2006 Mar; 4(3):229-36. PubMed ID: 16489349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation and use of the extracellular matrix by Trypanosoma cruzi during early infection.
    Nde PN; Lima MF; Johnson CA; Pratap S; Villalta F
    Front Immunol; 2012; 3():337. PubMed ID: 23133440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling the Trypanosoma cruzi Tc85-11 protein and mapping the laminin-binding site.
    Marroquin-Quelopana M; Oyama S; Aguiar Pertinhez T; Spisni A; Aparecida Juliano M; Juliano L; Colli W; Alves MJ
    Biochem Biophys Res Commun; 2004 Dec; 325(2):612-8. PubMed ID: 15530437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?
    Lima FM; Oliveira P; Mortara RA; Silveira JF; Bahia D
    N Biotechnol; 2010 Dec; 27(6):837-43. PubMed ID: 20172059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trypanosoma cruzi binds to laminin in a carbohydrate-independent way.
    Giordano R; Chammas R; Veiga SS; Colli W; Alves MJ
    Braz J Med Biol Res; 1994 Sep; 27(9):2315-8. PubMed ID: 7787815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.